Status:
COMPLETED
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if a physician-centered intervention will help women with early stage breast cancer receive appropriate treatment.
Detailed Description
Efficacious adjuvant treatments such as radiotherapy following breast conserving surgery, and chemo- or hormonal therapy for stage 1b or 2 breast cancer improve disease-free and overall survival. Lowe...
Eligibility Criteria
Inclusion
- All patients, who are English or Spanish speaking, with a new primary stage 1 or 2 breast cancer who have undergone either breast conserving surgery or mastectomy and those with tumors \> 1 cm or \< 1 cm and poorly differentiated
- All surgeons performing breast surgery at the participating hospitals
Exclusion
- Patients with dementia or those with a poor prognosis due to end-stage organ failure or other concomitant conditions such as those undergoing treatment for other cancers
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
1164 Patients enrolled
Trial Details
Trial ID
NCT00145197
Start Date
January 1 2004
End Date
December 1 2007
Last Update
December 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029